Krasney Karen
EVP, GENERAL COUNSEL
Krasney Karen has filed 5 SEC Form 4 filings (13 transaction rows) across 1 company, with disclosures dating back to 2026. 5 of those filings fall inside the rolling window. Most recent filing: Jun 30, 2026.
On the most recent filing, Krasney Karen is listed as EVP, GENERAL COUNSEL at CAPRICOR THERAPEUTICS, INC. Inside the rolling window, Krasney Karen reported no open-market purchases and 5 open-market sales totaling $2.3M in CAPR. The largest disclosed transaction in the window is a sale of 25,000 CAPR shares on May 1, 2026, worth $793K.
Companies traded
Other insiders at CAPR
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$2.3M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Krasney Karen made?
Krasney Karen has filed 5 SEC Form 4 filings (13 transaction rows) across 1 company since 2026.
Which companies does Krasney Karen trade?
Krasney Karen has filed SEC Form 4 disclosures for 1 company, including CAPR.
When was Krasney Karen's most recent SEC Form 4 filing?
Krasney Karen's most recent SEC Form 4 filing on Tracefour is dated Jun 30, 2026.
What is Krasney Karen's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Krasney Karen is listed as EVP, GENERAL COUNSEL.
What is Krasney Karen's total buy and sell value in the current window?
Inside the rolling retention window, Krasney Karen bought $0 and sold $2.3M based on SEC Form 4 filings.
What was Krasney Karen's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 25,000 CAPR shares on 2026-05-01, worth $793K, per SEC Form 4 filings.